Wireva

Late-Night Snacking Linked to 20-30% Higher Risk of Liver Disease

A study from Oregon Health & Science University and Massachusetts General Hospital finds that people who eat late at night face a 20 to 30 percent higher risk of liver disease than those who do not.

Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial
Teclistamab Shows Higher Response Rates Than Standard Therapy in High-Risk Smoldering Myeloma | Late-Night Snacking Linked to 20-30% Higher Risk of Liver Disease
Lenalidomide · Wikimedia — licence per file · rights

This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.

Monitoring item. The full text is not distributed. Extract and source below.

A study from Oregon Health & Science University and Massachusetts General Hospital finds that people who eat late at night face a 20 to 30 percent higher risk of liver disease than those who do not.

Same event, other desks

Story file →